Melaxib

Lactulose, Vaseline and Liquid Paraffin, the active ingredients in Melaxib, are a combination laxative presented as an oral solution for oral use. The formulation is intended to relieve constipation and to reduce ammonia absorption in hepatic encephalopathy, primarily in adult patients.

GNH USA supplies Melaxib as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, sourcing the product from EU manufacturers and ensuring regulatory compliance for global distribution. The company follows strict quality‑assurance protocols and provides reliable logistics for timely delivery.

Melaxib is used to manage conditions related to impaired bowel motility and ammonia accumulation. - Constipation: softens stool and promotes bowel movement, helping relieve occasional or chronic constipation. - Hepatic encephalopathy: reduces intestinal ammonia production, supporting management of hepatic encephalopathy in patients with liver disease. - Bowel preparation for diagnostic procedures: assists in clearing the colon when used as part of a preparation regimen.

Melaxib may cause a range of adverse reactions, most of which are mild and related to its laxative properties. Common Side Effects: - Abdominal cramping: mild discomfort in the abdomen. - Flatulence: increased intestinal gas. - Diarrhea: loose stools or increased frequency. - Nausea: feeling of sickness. Serious or Rare Side Effects: - Severe dehydration: marked fluid loss causing dizziness or low blood pressure. - Electrolyte imbalance: abnormal potassium or sodium levels. - Allergic reaction: rash, itching, swelling, or breathing difficulty. - Persistent abdominal pain: ongoing severe pain needing medical evaluation.

When using Melaxib, certain precautions should be observed to ensure safe and effective therapy. - Assess renal function: evaluate kidney status before initiating therapy, especially in patients with renal impairment. - Monitor electrolytes: check serum potassium and sodium periodically during prolonged use. - Use with caution in diabetes: lactulose may affect blood glucose control. - Avoid in intestinal obstruction: do not administer if there is known bowel blockage. - Pediatric use: limit to children only under medical supervision. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture.

Melaxib can interact with other medicines, altering their effectiveness or increasing adverse effects. Major Interactions (Avoid): - Antacids containing aluminum or magnesium: may reduce lactulose efficacy by affecting osmotic activity. - Antibiotics that alter gut flora: can diminish lactulose metabolism and its therapeutic effect. Moderate Interactions (Monitor Closely): - Diuretics: increased risk of electrolyte disturbances when combined with laxative effect. - Insulin or oral hypoglycemics: lactulose may affect glucose absorption, requiring dose adjustment. - Oral phosphate binders: may interfere with absorption of liquid paraffin.